Giant prolactinomas in women

The Prevalence and Natural History of Pituitary Hemorrhage in Prolactinoma

(2013) K. N. Sarwar et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas

(2011) Maria A Tichomirowa et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Increased prevalence of acromegaly in a highly polluted area

(2010) S Cannavò et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Prognostic Factors in Prolactin Pituitary Tumors: Clinical, Histological, and Molecular Data from a Series of 94 Patients with a Long Postoperative Follow-Up

(2010) Gérald Raverot et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Clinical management and outcome of 36 invasive prolactinomas treated with dopamine agonist

(2010) Moon Sool Yang et al.   JOURNAL OF NEURO-ONCOLOGY

Pituitary Tumors and Hyperplasia in Multiple Endocrine Neoplasia Type 1 Syndrome (MEN1): A Case-Control Study in a Series of 77 Patients Versus 2509 Non-MEN1 Patients

(2009) Jacqueline Trouillas et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Giant Prolactinoma and Effectiveness of Medical Management

(2009) Shrikrishna Acharya et al.   Endocrine Practice

Characterization of resistance to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patients

(2009) Etienne Delgrange et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Efficacy and Safety of Cabergoline as First Line Treatment for Invasive Giant Prolactinoma

(2009) Eun-Hee Cho et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Misdiagnosis due to the Hook Effect in Prolactin Assay

(2008) Serkan Yener et al.   MEDICAL PRINCIPLES AND PRACTICE